Sponsor
Anhui Provincial Hospital
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Anhui Provincial Hospital appears in 48 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
48 shownA Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)NCT06232083 · lead sponsor · 2025-09-01
RECRUITINGAnti CD19/BCMA CAR Gene Therapy for Autoimmune DiseasesNCT07121777 · lead sponsor · 2025-08-25
RECRUITINGIntravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's DiseaseNCT07208344 · lead sponsor · 2025-07-31
RECRUITINGCAR-T Cells Therapy for Patients With Autoimmune DiseasesNCT07052565 · lead sponsor · 2025-07-20
RECRUITINGHead-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and MetastasisNCT06756334 · lead sponsor · 2024-12-19
RECRUITINGThe Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate CancerNCT06737588 · lead sponsor · 2024-12-01
RECRUITINGComparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate CancerNCT06612047 · lead sponsor · 2024-10-08
RECRUITINGHypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung CancerNCT06527898 · lead sponsor · 2024-07-01
RECRUITINGTargeted Biopsy, Rapid Pathology, and Immediate Surgery in USTC High-Risk Prostate Cancer: A Prospective Multicenter StudyNCT07709338 · lead sponsor · 2026-08-01
NOT_YET_RECRUITINGCentrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLCNCT07523464 · lead sponsor · 2026-06-01
NOT_YET_RECRUITINGAn Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's DiseaseNCT07279844 · lead sponsor · 2025-12-15
NOT_YET_RECRUITINGA Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor TherapyNCT06760676 · lead sponsor · 2025-12-01
NOT_YET_RECRUITINGA Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)NCT07128251 · lead sponsor · 2025-08-20
NOT_YET_RECRUITINGiDAP Injection in the Treatment of Parkinson's DiseaseNCT06583291 · lead sponsor · 2024-10-01
NOT_YET_RECRUITINGPathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative BiopsyNCT06677775 · lead sponsor · 2024-08-30
UNKNOWNClinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's DiseaseNCT06889896 · lead sponsor · 2024-07-11
UNKNOWNRadiotherapy to All Residual Lesions After ChemoimmunotherapyNCT06479473 · lead sponsor · 2024-06-01
UNKNOWNSV2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive AlterationNCT06445582 · lead sponsor · 2024-06-01
UNKNOWNHead-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and MetastasisNCT06462508 · lead sponsor · 2024-04-20
UNKNOWNHead-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and MetastasisNCT06462495 · lead sponsor · 2024-04-10
UNKNOWNThe Treatment of High Intensity Transcranial Current Stimulation for Alzheimer's DiseaseNCT06380725 · lead sponsor · 2024-04-01
UNKNOWNConducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate CancerNCT05940415 · lead sponsor · 2023-10-08
UNKNOWNThe Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical ProstatectomyNCT05941104 · lead sponsor · 2023-07-15
UNKNOWNHead-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and MetastasisNCT05955677 · lead sponsor · 2023-07-10
UNKNOWNThe Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism PatientsNCT06010290 · lead sponsor · 2022-11-30
UNKNOWNRadical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic ModelNCT05587192 · lead sponsor · 2022-11-10
UNKNOWNHybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung CancerNCT05348668 · lead sponsor · 2022-05-09
COMPLETEDHypofraction Radiotherapy for Locally Advanced Non-small Cell Lung CancerNCT05269485 · lead sponsor · 2022-03-01
COMPLETEDHypofraction Radiotherapy for Limited-Stage Small Cell Lung CancerNCT05523908 · lead sponsor · 2022-02-01
COMPLETEDA Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3NCT06507462 · lead sponsor · 2021-01-01
COMPLETEDA Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2NCT03908749 · lead sponsor · 2019-04-10
UNKNOWNEndostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung AdenocarcinomaNCT02804646 · lead sponsor · 2016-06-01
UNKNOWNPre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)NCT07718126 · collaborator · 2026-09-01
RECRUITINGTo Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung CancerNCT07195084 · collaborator · 2025-09-20
RECRUITINGRC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II StudyNCT07065435 · collaborator · 2024-01-01
RECRUITINGDisitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II StudyNCT07446452 · collaborator · 2024-01-01
RECRUITINGDual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo TransferNCT07811895 · collaborator · 2026-09-01
NOT_YET_RECRUITINGStudy of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast CancerNCT07581795 · collaborator · 2026-06-01
NOT_YET_RECRUITINGEfficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.NCT07288749 · collaborator · 2026-01-01
NOT_YET_RECRUITINGSegmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCTNCT07169903 · collaborator · 2025-10-01
NOT_YET_RECRUITINGA Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney DiseaseNCT07130955 · collaborator · 2025-08-08
ENROLLING_BY_INVITATIONINSPIRE: a Multi-Cancer Early Detection StudyNCT06440018 · collaborator · 2024-07-20
UNKNOWNCadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)NCT05816499 · collaborator · 2023-02-16
UNKNOWNManagement of Oxaliplatin-related Gastroesophageal Variceal BleedingNCT05141617 · collaborator · 2021-11-03
UNKNOWNThe Treat-to-target Study of RA Based on Smart System of Disease Management(SSDM)NCT03715595 · collaborator · 2018-11-01
UNKNOWNImage Fusion of SPECT MPI and Fluoroscopy Venography to Guide LV Lead Placement for Improved CRT Response (GUIDE-CRT II)NCT03125720 · collaborator · 2017-04-14
COMPLETEDA National Registry on Chinese Patients With LymphangioleiomyomatosisNCT03193892 · collaborator · 2017-01-01
UNKNOWNThe Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line TreatmentNCT01796288 · collaborator · 2012-10-01
UNKNOWNSponsor roles
lead sponsor32
collaborator16
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.